HOME › DRUGS › AVACOPAN
ACTIVE SUBSTANCE / INN

AVACOPAN

Brand name(s): TAVNEOS, Tavneos
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA214487
Microscopic Polyangiitis;Wegener Granulomatosis
ACTIVE SUBSTANCE
Avacopan
REGULATORS
FDA · EMA
SPONSORS / MAH
Vifor Fresenius Medical Care Renal Pharma France, CHEMOCENTRYX
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TAVNEOSNDA214487CHEMOCENTRYXPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TavneosVifor Fresenius Medical Care Renal Pharma FranceAuthorised11/01/2022Microscopic Polyangiitis;Wegener Granulomatosis

FULL INTELLIGENCE ON AVACOPAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →